Default company panoramic image

Rainforest Pharmacal

Company is developing and commercializing proprietary safe and highly efficacious drugs derived from unique plants of the Amazon rainforest.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Cheyenne, WY, US
  • Currency USD
  • Founded September 2015
  • Employees 3
  • Website

Company Summary

The Company will identify and patent the active novel compound in a unique Amazon rainforest plant that has shown through extensive testing to be curative against brain, breast, prostrate, colorectal and luekemia cancers. Once the pre-clinical and clinical trials are perfrmed, the novel drug will be developed into internationally approved anti-cancer therapies. The world still has a great unmet need for curative, non-toxic oncology drugs.


  • Entrepreneur and owner of several companies. Served as the President of Global Pharmacal, Inc., a bio-pharmaceutical company located at the Texas Research Park in San Antonio, Texas. He has diverse skills including business start ups, development, marketing, sales and management. Masinter's passion is to develop breakthrough therapies that will help people and will benefit shareholders.

  • Default avatar
    Thomas E. Williams, Ph.D,
    Chief Scientific Officer

    Dr. Williams’ experience in the development of drugs for the treatment of cancer and hematologic malignancies spans more than 40 years: 22 years in pharmaceutical research and 20 in academia. In 1979, he joined Burroughs Wellcome Company where he served in various positions culminating as the Head of the Section of Oncology. In 2008, he co-founded Thistle Advisors International to provide oncology consultation for the pharmaceutical industry.


  • Default avatar
    Steven Butler
    Default avatar
    Randell Young

Previous Investors

  • Default avatar
    Dr. Ronald Zane
    Default avatar
    Robert McEver
    Default avatar
    Paul Thompson